KEZAR LIFE SCIENCES INC (KZR)

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

From Pennies to Fortunes: 3 Stocks Set to Make Millionaires

Discover how these stocks to make millionaires are leading in the gold, biotechnology, and application software industries.

Diamonds in the Dust: 3 Penny Stocks Set to Soar 500% by 2026

Learn how these penny stocks may yield a 5X return with their lead in application software and biotechnology.

KZR Stock Earnings: Kezar Life Sciences Misses EPS for Q4 2023

KZR stock results show that Kezar Life Sciences missed analyst estimates for earnings per share the fourth quarter of 2023.

KZR Stock Earnings: Kezar Life Sciences Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Kezar Life Sciences (NASDAQ:KZR) just reported results for the fourth quarter o...

Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Kezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference

Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis

Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis

/PRNewswire/ -- Everest Medicines (HKEX 1952.HK) and Kezar Life Sciences, Inc. (Nasdaq: KZR) announced today that the Center for Drug Evaluation (CDE) of...

3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond

When you want to light your afterburners, these ideas will do the trick.

3 Penny Stocks Poised for an Unbelievable 1,000% Jump

Discover penny stocks with the potential for a 1,000% leap: strategic growth, debt-free stability and pharmaceutical innovation await.

Bull Run Bonanza: Top 3 Penny Stocks Primed for Explosive Growth

Are you looking for the next bull run bonanza? Here are the top three penny stocks primed for explosive growth.

Kezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Kezar Life Sciences names new CEO, says to cut workforce by about 41% (NASDAQ:KZR)

Kezar Life Sciences (KZR) on Tuesday announced a strategic restructuring, including the reduction of its workforce by about 41%. Read more here.

Kezar Life Sciences Announces Strategic Restructuring to Prioritize Clinical-Stage Assets and Extend Financial Runway and Appoints Christopher Kirk, Ph.D. as Chief Executive Officer

Kezar Life Sciences and Everest Medicines Enter into an Agreement to Develop and Commercialize Zetomipzomib for Lupus Nephritis and other Potential Indications in Greater China, South Korea and Southeast Asia

Kezar Life Sciences to Participate in Three Upcoming Investor Conferences

Kezar Life Sciences Reports Second Quarter 2023 Financial Results and Provides Business Update

Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

RGEN, BGCP and TLS are among after hour movers (NASDAQ:KZR)

Gainers: Kezar Life Sciences (KZR) +6%. Telos Corporation (TLS) +4%

Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)